ImmunoCellular Therapeutics Ltd. (NY:IMUC)
Delayed: 2.56 -0.01 (0.39%)
Trade Now!
Previous Close $2.57    52 Week High $3.96 
Open $2.60    52 Week Low $1.51 
Day High $2.60    P/E N/A 
Day Low $2.54    EPS $-0.16 
Volume 307,302       

Friends, Peers and Foes (?): MNTR, GNBT, NWBO, ONTY, PVCT (more...)

May 16, 2013 06:00 AM ImmunoCellular Therapeutics Announces Issuance of Key Patent Covering ICT-107 Cancer Vaccine Target
May 15, 2013 06:05 AM Form 8-K ImmunoCellular Therapeut For: May 09
May 10, 2013 06:02 AM Form 10-Q ImmunoCellular Therapeut For: Mar 31
May 9, 2013 04:00 PM ImmunoCellular Therapeutics Announces First Quarter 2013 Financial Results
May 2, 2013 12:19 PM Mentor Capital Cancer Immunotherapy Index Gains 28% During First Quarter of 2013
May 1, 2013 06:00 AM ImmunoCellular Therapeutics to Report Financial Results for the First Quarter 2013 May 9, 2013
Apr 18, 2013 04:11 PM Form 8-K ImmunoCellular Therapeut For: Apr 18
Mar 28, 2013 06:00 AM ImmunoCellular Therapeutics to Present at Future Leaders Conference on April 5th
Mar 5, 2013 04:02 PM Immunocellular Therapeutics, Ltd. (IMUC) Tops Q4 EPS by 9c
Jan 29, 2013 06:06 AM FDA Allows ImmunoCellular's (IMUC) IND for ICT-140
View All Articles

Entities mentioned with IMUC

View All Entities